Karen Akinsanya, President of R&D, Therapeutics: Schrodinger SDGR Planned sale · Filed 25/04/14

Trade details

Type: Planned sale notice
Stock: Schrodinger SDGR
Person: Karen AkinsanyaPresident of R&D, Therapeutics
Planned sale date: 25/04/14
Filed: 25/04/14

$409.5K to be sold

Schrodinger trades, last 26 weeks

What else happened in Schrodinger around then

Filed or reported within 30 days of the trade day · 25/03/15~25/05/14

Karen Akinsanya's recent trades

Karen AkinsanyaOfficer
Planned sale10b5-1 planSchrodinger
Planned sale10b5-1 plan
Schrodinger
SDGR
$756.2K
31,599 sh
$756.2K
Filed 09/17
Traded 09/17
Karen AkinsanyaSEE REMARKS
Sell10b5-1 planSchrodinger
Sell10b5-1 plan
Schrodinger
SDGR
$17.6K
1,366 sh
$17.6K
Filed 03/06
Traded 03/05
Karen AkinsanyaOfficer
Planned saleSchrodinger
Planned sale
Schrodinger
SDGR
$17.6K
1,366 sh
$17.6K
Filed 03/05
Traded 03/05
Karen AkinsanyaSEE REMARKS
Sell10b5-1 planSchrodinger
Sell10b5-1 plan
Schrodinger
SDGR
$26.4K
2,206 sh
$26.4K
Filed 03/03
Traded 03/02
Karen AkinsanyaOfficer
Planned saleSchrodinger
Planned sale
Schrodinger
SDGR
$26.5K
2,206 sh
$26.5K
Filed 03/02
Traded 03/02